Grant Offers Hope for Hemorrhagic Fevers

By Arthur Nead

Daniel Bausch

The National Institute of Allergies and Infectious Diseases, part of the National Institutes of Health, has awarded a five-year contract totaling more than $15 million to Tulane University for its ongoing efforts to treat and prevent Lassa fever, an often deadly viral disease that threatens hundreds of thousands of people annually in West Africa and is classified as a potential bioterrorism threat.

Daniel Bausch, associate professor of tropical medicine at the Tulane School of Public Health and Tropical Medicine, is a member of the team that was awarded the

grant and is the director of the Tulane Research and Training Program in the Mano River Union Region of West Africa.

“This study will result in a fundamental understanding of the mechanisms of antibody responses and how they neutralize the Lassa virus,” says James Robinson, professor of pediatrics in the Tulane School of Medicine and principal investigator for the project.

Bausch says that the group intends to expand this program to other infectious agents such as Ebola, Marburg and other hemorrhagic fever viruses that are of concern to the public health and bioterrorism preparedness communities.


About Tulane University SPHTM

Tulane's School of Public Health and Tropical Medicine is the oldest school of public health in the country and the only American school of tropical medicine. Our mission is to advance public health knowledge, promote health and well-being, and prevent disease, disability, and premature mortality. This is accomplished through academic excellence in education of public health professionals, rigorous scientific research of public health problems, creative partnerships to advance the practice of public health, and innovative service to the local, national, and international public health community.
This entry was posted in Spring 2010 and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s